澳大利亚国家健康与医学研究委员会(NHMRC)发布了关于青春期阻断剂的初步建议。该建议指出,对于患有“性别不一致”的18岁以下青少年,可在个案评估基础上考虑使用该药物 1。建议明确强调,患者无需经历严重痛苦或被诊断为精神障碍即可考虑接受治疗 1。尽管NHMRC的系统综述将总体证据等级评为“低确定性”,但其结论认为,对部分年轻人而言,潜在收益可能超过风险 1。这一立场与英国及美国部分州日益严格的限制趋势形成对比,旨在为各州重新审视相关限制提供国家层面的依据 1。
目前,西澳大利亚州和昆士兰州公共服务中分别有58人和77名年轻人正在接受阻断剂治疗,占两地未成年人总数的约0.007% 1。公众咨询期截至2024年1月18日,最终临床指南计划于2028年发布 1。值得注意的是,NHMRC的建议不具有法律约束力,各州和地区自行决定其公共卫生服务如何提供护理 1。此前,昆士兰州自2025年1月起已停止新患者在公共卫生系统中开始使用青春期阻断剂或性别确认激素,北领地也禁止在公立系统中使用 1。
Australia’s National Health and Medical Research Council (NHMRC) has released draft guidance suggesting that puberty blockers may be considered for young people under the age of 18 diagnosed with gender incongruence, subject to individual case assessments 1. The advisory body concluded that while the overall certainty of evidence is rated as low, the potential benefits of treatment may outweigh the risks for certain individuals 1. Notably, the guidelines specify that patients do not need to be diagnosed with a mental disorder or experience extreme distress to qualify for consideration of this medical intervention 1.
The release of this national framework comes amidst varying regional policies across Australia. Currently, public health services in Western Australia and Queensland are treating 58 and 77 young people with puberty blockers respectively, figures which represent approximately 0.007% of the minor population in those states 1. However, restrictions have tightened elsewhere; since January 2025, Queensland has halted new starts of puberty blockers or gender-affirming hormones within its public system, and the Northern Territory has also banned their use in public healthcare facilities 1. It is important to note that the NHMRC’s advice does not carry legal binding force, leaving each state and territory to determine how their respective public health services deliver care 1.
The public consultation period for these initial recommendations closed on January 18, 2024 1. According to the NHMRC’s timeline, final clinical guidelines regarding the use of puberty blockers are scheduled for release in 2028 1. This national-level input aims to provide a basis for states reviewing existing limitations, contrasting with increasingly restrictive trends observed in parts of the United Kingdom and some US states 1.
评论
还没有评论,欢迎留下第一条。